• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SCHEDULE 13G/A filed by Enfusion Inc.

    1/31/25 4:28:29 PM ET
    $ENFN
    Computer Software: Prepackaged Software
    Technology
    Get the next $ENFN alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13G


    UNDER THE SECURITIES EXCHANGE ACT OF 1934
    (Amendment No. 3)


    Enfusion, Inc.

    (Name of Issuer)


    Class A common stock

    (Title of Class of Securities)


    292812104

    (CUSIP Number)


    12/31/2024

    (Date of Event Which Requires Filing of this Statement)


    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    Checkbox not checked   Rule 13d-1(b)
    Checkbox not checked   Rule 13d-1(c)
    Checkbox checked   Rule 13d-1(d)






    SCHEDULE 13G

    CUSIP No.
    292812104


    1Names of Reporting Persons

    Malherbe Investments LLC
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    6,870,386.00
    6Shared Voting Power

    0.00
    7Sole Dispositive Power

    6,870,386.00
    8Shared Dispositive Power

    0.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    6,870,386.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    6.79 %
    12Type of Reporting Person (See Instructions)

    OO

    Comment for Type of Reporting Person:  Rows 5, 7 and 9 represent 6,870,386 shares of Class A common stock that Malherbe Investments LLC has the right to acquire upon the exchange of common units of Enfusion Ltd. LLC. Percentage in Row 11 is based on 101,242,457 shares of Class A Common Stock outstanding, which is the sum of (i) 94,372,071 shares of Class A Common Stock outstanding as of October 31, 2024, as reported in the Issuer's Quarterly Report on Form 10-Q filed on November 4, 2024, and (ii) the 6,870,386 shares of Class A Common Stock that Malherbe Investments LLC has the right to acquire upon the exchange of common units of Enfusion Ltd. LLC, which shares have been added to the total shares of Class A Common Stock outstanding pursuant to Rule 13d-3(d)(1)(i)(D) under the Exchange Act.


    SCHEDULE 13G

    CUSIP No.
    292812104


    1Names of Reporting Persons

    Stephen Malherbe
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    6,870,386.00
    6Shared Voting Power

    0.00
    7Sole Dispositive Power

    6,870,386.00
    8Shared Dispositive Power

    0.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    6,870,386.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    6.79 %
    12Type of Reporting Person (See Instructions)

    IN

    Comment for Type of Reporting Person:  Rows 5, 7 and 9 represent 6,870,386 shares of Class A common stock that Malherbe Investments LLC has the right to acquire upon the exchange of common units of Enfusion Ltd. LLC. Percentage in Row 11 is based on 101,242,457 shares of Class A Common Stock outstanding, which is the sum of (i) 94,372,071 shares of Class A Common Stock outstanding as of October 31, 2024, as reported in the Issuer's Quarterly Report on Form 10-Q filed on November 4, 2024, and (ii) the 6,870,386 shares of Class A Common Stock that Malherbe Investments LLC has the right to acquire upon the exchange of common units of Enfusion Ltd. LLC, which shares have been added to the total shares of Class A Common Stock outstanding pursuant to Rule 13d-3(d)(1)(i)(D) under the Exchange Act.


    SCHEDULE 13G

    Item 1. 
    (a)Name of issuer:

    Enfusion, Inc.
    (b)Address of issuer's principal executive offices:

    125 South Clark Street, Suite 750, Chicago, Illinois 60603
    Item 2. 
    (a)Name of person filing:

    This statement is filed by Malherbe Investments LLC and Stephen Malherbe (together, the "Reporting Persons"). Mr. Malherbe is the sole manager of Malherbe Investments LLC and may be deemed the beneficial owner of the shares held by Malherbe Investments LLC.
    (b)Address or principal business office or, if none, residence:

    The principal business office address of the Reporting Persons is 1063 Gallant Court, Wheaton, Illinois 60187.
    (c)Citizenship:

    Malherbe Investments LLC is a Delaware limited liability company and Stephen Malherbe is a citizen of the United States of America.
    (d)Title of class of securities:

    Class A common stock
    (e)CUSIP No.:

    292812104
    Item 3.If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
    (a)Checkbox not checked   Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
    (b)Checkbox not checked   Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
    (c)Checkbox not checked   Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
    (d)Checkbox not checked   Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
    (e)Checkbox not checked   An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
    (f)Checkbox not checked   An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
    (g)Checkbox not checked   A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
    (h)Checkbox not checked   A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i)Checkbox not checked   A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
    (j)Checkbox not checked   A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
           please specify the type of institution:
    (k)Checkbox not checked   Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
     
    Item 4.Ownership
    (a)Amount beneficially owned:

    See responses to Item 9 on each cover page hereto.
    (b)Percent of class:

    See responses to Item 11 on each cover page hereto.
    (c)Number of shares as to which the person has:
     (i) Sole power to vote or to direct the vote:

    See responses to Item 5 on each cover page hereto.

     (ii) Shared power to vote or to direct the vote:

    See responses to Item 6 on each cover page hereto.

     (iii) Sole power to dispose or to direct the disposition of:

    See responses to Item 7 on each cover page hereto.

     (iv) Shared power to dispose or to direct the disposition of:

    See responses to Item 8 on each cover page hereto.

    Item 5.Ownership of 5 Percent or Less of a Class.
     
    Item 6.Ownership of more than 5 Percent on Behalf of Another Person.
     
    Not Applicable
    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
     
    Not Applicable
    Item 8.Identification and Classification of Members of the Group.
     
    Not Applicable
    Item 9.Notice of Dissolution of Group.
     
    Not Applicable

    Item 10.Certifications:
     
    Not Applicable

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    Malherbe Investments LLC
     
    Signature:/s/ Stephen Malherbe
    Name/Title:Sole Manager
    Date:01/31/2025
     
    Stephen Malherbe
     
    Signature:/s/ Stephen Malherbe
    Name/Title:Stephen Malherbe
    Date:01/31/2025
    Get the next $ENFN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ENFN

    DatePrice TargetRatingAnalyst
    5/10/2024$11.00Overweight
    Morgan Stanley
    2/28/2024$9.00 → $8.00Neutral → Sell
    Goldman
    1/30/2024$11.00 → $9.00Neutral → Underweight
    JP Morgan
    11/7/2023$9.00Neutral
    UBS
    4/3/2023$11.00Neutral
    Piper Sandler
    3/15/2023$12.00Neutral
    JP Morgan
    1/4/2023$15.00 → $10.00Neutral → Underperform
    BofA Securities
    1/3/2023$13.00 → $12.00Equal-Weight → Overweight
    Morgan Stanley
    More analyst ratings

    $ENFN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Morgan Stanley resumed coverage on Enfusion with a new price target

    Morgan Stanley resumed coverage of Enfusion with a rating of Overweight and set a new price target of $11.00

    5/10/24 8:40:24 AM ET
    $ENFN
    Computer Software: Prepackaged Software
    Technology

    Enfusion downgraded by Goldman with a new price target

    Goldman downgraded Enfusion from Neutral to Sell and set a new price target of $8.00 from $9.00 previously

    2/28/24 6:16:11 AM ET
    $ENFN
    Computer Software: Prepackaged Software
    Technology

    Enfusion downgraded by JP Morgan with a new price target

    JP Morgan downgraded Enfusion from Neutral to Underweight and set a new price target of $9.00 from $11.00 previously

    1/30/24 6:55:00 AM ET
    $ENFN
    Computer Software: Prepackaged Software
    Technology

    $ENFN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Iconiq Strategic Partners V, L.P. disposed of 9,009,594 shares (SEC Form 4)

    4 - Enfusion, Inc. (0001868912) (Issuer)

    4/23/25 4:30:12 PM ET
    $ENFN
    Computer Software: Prepackaged Software
    Technology

    Director Luo Roy returned 9,009,594 shares to the company (SEC Form 4)

    4 - Enfusion, Inc. (0001868912) (Issuer)

    4/23/25 4:30:09 PM ET
    $ENFN
    Computer Software: Prepackaged Software
    Technology

    Chief Operating Officer Pawar Neal returned 1,217,308 shares to the company, closing all direct ownership in the company (SEC Form 4)

    4 - Enfusion, Inc. (0001868912) (Issuer)

    4/21/25 5:11:16 PM ET
    $ENFN
    Computer Software: Prepackaged Software
    Technology

    $ENFN
    SEC Filings

    View All

    SEC Form 15-12G filed by Enfusion Inc.

    15-12G - Enfusion, Inc. (0001868912) (Filer)

    5/1/25 4:15:29 PM ET
    $ENFN
    Computer Software: Prepackaged Software
    Technology

    SEC Form EFFECT filed by Enfusion Inc.

    EFFECT - Enfusion, Inc. (0001868912) (Filer)

    4/24/25 12:15:09 AM ET
    $ENFN
    Computer Software: Prepackaged Software
    Technology

    SEC Form POS AM filed by Enfusion Inc.

    POS AM - Enfusion, Inc. (0001868912) (Filer)

    4/21/25 4:57:41 PM ET
    $ENFN
    Computer Software: Prepackaged Software
    Technology

    $ENFN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    OPENLANE Names Brad Herring Chief Financial Officer

    Bolsters Leadership Bench With More Than 30 Years of Financial Management and Investor Relations Expertise CARMEL, Ind., April 22, 2025 /PRNewswire/ -- OPENLANE, Inc. (NYSE:KAR), a leading operator of digital marketplaces for wholesale used vehicles, announces the company has named Brad Herring as EVP and Chief Financial Officer effective May 27, 2025. Herring will be responsible for leading all financial, reporting and investor-facing functions across OPENLANE, including the company's capital investment strategy. Herring also joins OPENLANE's executive team and will report to CEO Peter Kelly.

    4/22/25 4:15:00 PM ET
    $ENFN
    $FOUR
    $KAR
    Computer Software: Prepackaged Software
    Technology
    Real Estate
    Retail-Auto Dealers and Gas Stations

    Clearwater Analytics Finalizes Acquisition of Enfusion

    Clearwater Will Deliver Industry's First Unified, Cloud-Native Front-to-Back Platform for Institutional Investors Clearwater Analytics (NYSE:CWAN), the most comprehensive technology platform for investment management, today announced the successful completion of its acquisition of Enfusion, Inc. (NYSE:ENFN), a leader in software-as-a-service (SaaS) solutions for the investment management and hedge fund sectors, in a deal valued at approximately $1.5 billion. This strategic combination positions Clearwater as the industry's first single-instance, multi-tenant, cloud-native platform to unify front, middle, and back-office investment operations. By integrating portfolio and order management,

    4/21/25 4:15:00 PM ET
    $CWAN
    $ENFN
    Computer Software: Prepackaged Software
    Technology

    Clearwater Analytics and Enfusion Announce Preliminary Results of Election by Enfusion Shareholders Regarding Form of Merger Consideration

    Clearwater Analytics (NYSE:CWAN) ("Clearwater") and Enfusion, Inc. (NYSE:ENFN) ("Enfusion") today announced the preliminary results of the elections made by Enfusion shareholders of record regarding the form of merger consideration (the "Merger Consideration") they wish to receive in connection with Clearwater's acquisition of Enfusion (the "Transaction"). As previously disclosed, the deadline to have made such an election was 5:00 p.m. Eastern Time on April 16, 2025 (the "Election Deadline"). The parties expect to close the Transaction on April 21, 2025, subject to the approval of the Transaction by Enfusion shareholders and the satisfaction or waiver of other customary closing conditions

    4/17/25 8:00:00 AM ET
    $CWAN
    $ENFN
    Computer Software: Prepackaged Software
    Technology

    $ENFN
    Financials

    Live finance-specific insights

    View All

    Clearwater Analytics Finalizes Acquisition of Enfusion

    Clearwater Will Deliver Industry's First Unified, Cloud-Native Front-to-Back Platform for Institutional Investors Clearwater Analytics (NYSE:CWAN), the most comprehensive technology platform for investment management, today announced the successful completion of its acquisition of Enfusion, Inc. (NYSE:ENFN), a leader in software-as-a-service (SaaS) solutions for the investment management and hedge fund sectors, in a deal valued at approximately $1.5 billion. This strategic combination positions Clearwater as the industry's first single-instance, multi-tenant, cloud-native platform to unify front, middle, and back-office investment operations. By integrating portfolio and order management,

    4/21/25 4:15:00 PM ET
    $CWAN
    $ENFN
    Computer Software: Prepackaged Software
    Technology

    Enfusion Announces Fourth Quarter and Full Year 2024 Results

    Enfusion, Inc. ("Enfusion") (NYSE:ENFN), a leading provider of software-as-a-service (SaaS) solutions for investment managers, today announced financial results for the fourth quarter and full year ended December 31, 2024. Fourth Quarter 2024 Financial Highlights: Total revenue was $52.9 million, up 13.9% compared to the same period in the prior year. Gross Profit was $36.5 million with a Gross Profit Margin of 69.0%. Adjusted Gross Profit was $36.9 million with an Adjusted Gross Profit Margin of 69.6%. Net Income was $0.2 million with a Net Income Margin of 0.3%. Adjusted EBITDA was $12.3 million, up 25.3% compared to the same period in the prior year. Operating Cash Fl

    3/3/25 4:05:00 PM ET
    $ENFN
    Computer Software: Prepackaged Software
    Technology

    Clearwater Analytics to Acquire Enfusion for $1.5 Billion Expanding its Investment Management Platform with Front-to-Back Capabilities

    Investor Conference Call Scheduled for Today at 8:30 a.m. ET Clearwater Analytics (NYSE:CWAN) ("Clearwater") and Enfusion, Inc. (NYSE:ENFN) ("Enfusion") today announced their entry into a definitive merger agreement for Clearwater to acquire Enfusion, a leader in software-as-a-service (SaaS) solutions for the investment management and hedge fund industry. The purchase price is $11.25 per share, delivered in an approximately equal mix of cash and stock. Additionally, Clearwater will pay $30 million to terminate Enfusion's tax receivable agreement (TRA). This equates to a purchase price of approximately $1.5 billion. This press release features multimedia. View the full release here: https

    1/13/25 6:30:00 AM ET
    $CWAN
    $ENFN
    Computer Software: Prepackaged Software
    Technology

    $ENFN
    Leadership Updates

    Live Leadership Updates

    View All

    FTV Capital Named to Inc.'s Founder-Friendly Investors List for Fourth Consecutive Year

    FTV Capital, a leading sector-focused growth equity investment firm, today announced its inclusion for the fourth consecutive year on Inc.'s annual Founder-Friendly Investors list, which honors the private equity, venture capital firms and lenders with a track record of backing founder-led companies. This year's list recognizes 269 firms that believe in backing founder-led businesses and helping them thrive, demonstrated by their successful track records of collaboration and remaining actively involved with their portfolio companies to drive growth. "We are honored to be recognized again by Inc. for our ongoing commitment to serving as a collaborative, strategic partner to founders and ent

    10/29/24 7:00:00 AM ET
    $ENFN
    $GLOB
    Computer Software: Prepackaged Software
    Technology
    EDP Services

    Enfusion Announces Key Leadership Team Additions to Drive Client Success and Fuel Innovation

    Appointments of Arman Artuc to Head of Engineering, and Jesper Cordes to Head of Client Services Americas, Will Further Elevate Enfusion's Operations as an Investment Technology Industry Leader Enfusion, Inc. ("Enfusion") (NYSE:ENFN), a leading provider of software-as-a-service (SaaS) solutions for investment managers, announced today the appointments of Arman Artuc to Head of Engineering and Jesper Cordes to Head of Client Services Americas. These additions to the leadership team reinforce the company's position as a global leader in investment technology and services, which enables Enfusion to continue to attract top-performing industry experts and innovators to its ranks. Enfusion is s

    10/10/24 9:00:00 AM ET
    $ENFN
    Computer Software: Prepackaged Software
    Technology

    ZEMA Global Data Corporation to Acquire Morningstar Commodity Data

    Transformative acquisition will position ZEMA as global leader in offering high-quality enterprise data management and analytics for the energy and commodities industry ZEMA Global Data Corporation (formerly ZE PowerGroup), a leading provider of enterprise data management and analytics for the commodity and energy sectors, today announced its plans to acquire Morningstar Commodity Data, a provider of commodities and energy data and insights. The transaction is expected to close later this month. The business will serve a diverse portfolio of over 200 enterprises with an expanded product offering and broader geographic operations to support customers around the world. The announcement come

    9/23/24 8:00:00 AM ET
    $ENFN
    $GLOB
    Computer Software: Prepackaged Software
    Technology
    EDP Services

    $ENFN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Enfusion Inc.

    SC 13G/A - Enfusion, Inc. (0001868912) (Subject)

    10/29/24 7:13:25 PM ET
    $ENFN
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13G/A filed by Enfusion Inc.

    SC 13G/A - Enfusion, Inc. (0001868912) (Subject)

    10/25/24 4:30:55 PM ET
    $ENFN
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13G/A filed by Enfusion Inc.

    SC 13G/A - Enfusion, Inc. (0001868912) (Subject)

    9/6/24 3:32:03 PM ET
    $ENFN
    Computer Software: Prepackaged Software
    Technology